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Abstract
Background: The Zap1 transcription factor is a central player in the response of yeast to changes
in zinc status. We previously used transcriptome profiling with DNA microarrays to identify 46
potential Zap1 target genes in the yeast genome. In this new study, we used complementary
methods to identify additional Zap1 target genes.
Results: With alternative growth conditions for the microarray experiments and a more sensitive
motif identification algorithm, we identified 31 new potential targets of Zap1 activation. Moreover,
an analysis of the response of Zap1 target genes to a range of zinc concentrations and to zinc
withdrawal over time demonstrated that these genes respond differently to zinc deficiency. Some
genes are induced under mild zinc deficiency and act as a first line of defense against this stress.
First-line defense genes serve to maintain zinc homeostasis by increasing zinc uptake, and by
mobilizing and conserving intracellular zinc pools. Other genes respond only to severe zinc
limitation and act as a second line of defense. These second-line defense genes allow cells to adapt
to conditions of zinc deficiency and include genes involved in maintaining secretory pathway and
cell wall function, and stress responses.
Conclusion: We have identified several new targets of Zap1-mediated regulation. Furthermore,
our results indicate that through the differential regulation of its target genes, Zap1 prioritizes
mechanisms of zinc homeostasis and adaptive responses to zinc deficiency.
Background
Organisms require mechanisms to survive under adverse
conditions of extreme heat, osmolarity, nutrient limita-
tion, and other stresses. Recent studies have begun to
probe the cellular responses to the stress of zinc defi-
ciency. Zinc is a critical cofactor for many proteins and
plays important roles in myriad biological processes.
Therefore, when zinc becomes limiting, cells must
respond to maintain zinc homeostasis. In addition, cells
may alter their metabolic processes to adapt to growth
under conditions where certain zinc-dependent proteins
are less active. We are examining the cellular responses to
zinc deficiency in the yeast Saccharomyces cerevisiae.
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In this yeast, the Zap1 transcription factor is a central
player in the response to zinc deficiency [1]. For many of
its target genes, Zap1 acts as an activator of transcription
and increases gene expression when zinc levels are low. To
perform this function, Zap1 binds to Zinc-Responsive Ele-
ments or "ZREs" in the promoters of its target genes [2].
The consensus sequence for a ZRE is ACCTTNAAGGT.
While some Zap1 target genes contain multiple functional
ZREs, many others have only a single binding site [2,3].
The Zap1 protein is 880 amino acids long. A DNA binding
domain consisting of five zinc fingers is found at its car-
boxy terminus [4,5]. In addition, Zap1 contains two inde-
pendent activation domains, designated AD1 and AD2,
that mediate the increased transcription of target genes
[6]. Zap1 is a direct sensor of cellular zinc levels. The pro-
tein resides in the nucleus under all conditions of zinc sta-
tus [6]. When zinc levels rise, the metal binds to ligand
residues in the AD1 and AD2 regions of the protein and
this binding inhibits the ability of these domains to pro-
mote transcription [6-10]. Alteration of these regulatory
zinc-binding ligands by mutation decreases the ability of
Zap1 to respond to zinc and the mutant protein constitu-
tively activates transcription [7,10].
Previous studies have identified a large number of poten-
tial Zap1 target genes in the yeast genome [3,11,12]. Many
of these genes act to maintain sufficient levels of cytosolic
zinc available for cell growth. For example, the ZRT1,
ZRT2, and FET4 genes encode zinc transporters responsi-
ble for zinc uptake across the plasma membrane [13-15].
These genes are induced by Zap1 in zinc-limited cells.
Zap1 also induces expression of the ZRT3 gene in low
zinc; ZRT3 encodes a vacuolar membrane protein respon-
sible for transporting zinc stored in the vacuole to the
cytoplasm for its utilization [16]. As a final example, Zap1
induces transcription of its own gene in a positive autoreg-
ulatory loop [1]. Thus, Zap1 levels rise in zinc-limited
cells and this may lead to increased expression of other
target genes.
In addition to its role in activating gene expression, Zap1
can also act as a transcriptional repressor. Previous studies
have identified two different mechanisms of Zap1-medi-
ated repression. The ZRT2 gene provided the first exam-
ple. ZRT2 is unusual among Zap1 target genes in that it is
induced by mild zinc limitation and repressed by more
severe zinc deficiency [17]. This paradoxical pattern of
regulation is due to the presence of three ZREs in the ZRT2
promoter. Two high affinity ZREs, ZRE1 and ZRE2, are
located upstream of the TATA box and these elements
mediate Zap1-dependent activation of gene expression.
The third ZRE, ZRE3, has a low affinity of Zap1 binding
and is located downstream of the TATA box. ZRE3 is
essential for repression of ZRT2 expression. Under mild
conditions of zinc deficiency, Zap1 binds to ZRE1 and
ZRE2 and activates gene expression. Under severe zinc
deficiency, Zap1 levels rise due to autoregulation and the
protein then binds to ZRE3 and interferes with ZRT2
expression possibly by blocking transcription initiation.
The ADH1 and ADH3 genes provide examples of a second
mechanism of Zap1-mediated repression. ADH1  and
ADH3  encode zinc-dependent alcohol dehydrogenases.
These genes are highly expressed in zinc-replete cells but
are repressed in zinc-deficient cells [18]. Zap1 mediates
ADH1  and  ADH3  repression in low zinc by means of
intergenic transcripts that are activated by Zap1 and tran-
scribed through the ADH1 and ADH3 promoters. These
intergenic transcripts, designated ZRR1 and ZRR2 respec-
tively, do not encode protein products but rather their
synthesis results in the transient displacement of tran-
scription factors normally required for ADH1 and ADH3
expression. This results in the reduced expression of two
of the most abundant zinc-binding proteins in the cell.
Conversely, the ADH4 gene is induced by Zap1 and this
gene encodes a potential iron-dependent alcohol dehy-
drogenase [3,18,19]. By switching from zinc-dependent to
zinc-independent ADH isozymes, the cell may conserve
zinc for other uses. Alternatively, Adh4 may use zinc as its
cofactor [20] but this protein is predicted to bind only one
zinc per monomer while Adh1 and Adh3 each bind two.
Thus, zinc conservation could occur under this scenario as
well.
DNA microarrays have been remarkably useful in assess-
ing the transcriptional responses of an organism such as
yeast to stress conditions [3,11,12]. In a previous study,
we used microarrays to identify likely Zap1 target genes in
the yeast genome, a group of genes that we referred to as
the Zap1 "regulon" [3]. In that study, we identified a total
of 46 genes in yeast that are potential targets of Zap1 acti-
vation. As described below, we have further addressed this
issue using revised experimental approaches. This new
analysis has led to the identification of many new poten-
tial Zap1 target genes. In addition, we have characterized
the differential regulation of Zap1 target genes. We found
that some genes respond to mild zinc deficiency and act as
a first line of defense against this stress. These first-line
defense genes participate in various mechanisms of zinc
homeostasis. Other Zap1 target genes respond only to
severe conditions of zinc limitation and serve as a second
line of defense. Second-line defense genes act largely in
the adaptation to conditions where zinc availability is
insufficient to maintain optimal cell function.
Results
Identification of new Zap1 target genes
Our previous study suggested that Zap1 may directly acti-
vate the expression of as many as 46 different genes [3].BMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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That study used genome-wide transcription profiling with
DNA microarrays coupled with a motif identification
algorithm, MEME. Specifically, we first compared gene
expression in wild type cells grown in low and high zinc
and identified 458 genes expressed more highly in low
zinc in duplicate microarrays. We refer to this as "Experi-
ment 1" or "E1." We then compared gene expression in
wild type and zap1Δ mutant cells grown in low zinc and
identified 214 genes that were expressed at a higher level
in wild type cells in duplicate arrays. We refer to this con-
dition as "Experiment 2" or "E2." A set of 111 genes
showed increased expression in both E1 and E2. MEME
identified potential ZRE sequences located within the pro-
moter regions of 46 of the 111 genes. These results sug-
gested that these 46 genes are direct targets of Zap1 gene
regulation.
In this current study, we have further characterized the
Zap1 regulon using additional microarray experiments
and a more sensitive motif identification algorithm. First,
we devised a third microarray experiment to identify Zap1
target genes. Since our previous analysis, we have gener-
ated alleles of Zap1 that are constitutive and poorly regu-
lated by zinc. One such allele, designated "Zap1TC", was
used in this study. The Zap1TC allele contains mutations in
or near the two activation domains of Zap1 that render
those domains less responsive to zinc [7]. We predicted
that Zap1 target genes would show increased expression
in zinc-replete cells overexpressing the Zap1TC  allele.
Microarray experiments were performed in which wild-
type cells expressing the Zap1TC allele and wild-type cells
bearing the vector only were grown in high zinc condi-
tions. We refer to this as "Experiment 3" or "E3." Expres-
sion of 379 genes increased in Zap1TC-expressing cells an
average of ≥ 1.5-fold in duplicate arrays. When combined
with our previous results, a total of 53 genes were found
to have the expected alterations of expression in E1, E2,
and E3 conditions (Fig. 1A).
While MEME was very useful for our previous analysis, we
became concerned about the ability of this algorithm to
identify functional ZREs. For example, MEME was unable
to identify experimentally confirmed ZREs in the promot-
ers of the ZRT2, PIS1, and EKI1 genes [17,21,22] (data not
shown). These observations suggested that MEME was not
sufficiently sensitive to identify all potential ZREs within
a collection of target gene promoters. Therefore, we ana-
lyzed the promoters of the 53 candidate genes (Fig. 1A)
using a more sensitive motif identification algorithm
called Regulatory Sequence Analysis Tools or RSAT. With
RSAT, a position-specific probability matrix was generated
using the ZREs identified by MEME and a representation
of that consensus sequence is provided in Fig. 1B. This
matrix was then used to search for additional ZRE-like
sequences in the promoters of these genes. Sequences
were scored based on their similarity to the probability
matrix with higher scores indicating greater similarity. An
RSAT score of 4.5 was used as a minimum cut-off value in
this analysis because this is the lowest score obtained for
a bona fide ZRE found in the EKI1 promoter [21]. Our rea-
soning was that sequences scoring ≥ 4.5 were strong can-
didates for functional ZREs. Among the 53 genes
implicated to be Zap1 targets by the combination of E1,
E2, and E3, the promoters of 49 genes contain one or
more potential ZREs identified by RSAT and these are
listed in Tables 1 and 2. Table 1 lists 33 genes that were
identified as potential Zap1 targets in our previous exper-
iments. While several of these have been demonstrated to
be Zap1 targets by additional experiments (DPP1, IZH1,
etc), several others (MOH1, TKL2, etc.) had not been fur-
ther characterized since our initial analysis. For all genes
listed, the new E3 analysis provided additional experi-
mental support that these genes are indeed Zap1 targets.
Table 2 lists 16 new candidate Zap1 target genes identified
in this study. These genes were not identified in our previ-
ous analysis due to the insensitivity of MEME in detecting
ZRE-like sequences. This group includes HSP26, SED1,
CTT1, and TSA1.
We noted that 13 of the 46 Zap1 target genes previously
identified were not clearly up-regulated in cells expressing
the Zap1TC allele (E3). The E1, E2, and E3 results for these
genes are provided in Additional file 1. While several of
these genes showed increased expression in the Zap1TC-
expressing cells, these increases did not satisfy our cut-off
criteria. It is unclear at this time why these genes were less
responsive to the constitutive Zap1 allele than other tar-
gets. We also found that 4 genes (ALD2, PIR3, YBR285W,
YNR066C) showed increased expression in E1, E2, and E3
but did not contain ZREs in their promoters that were
detectable by RSAT (Additional file 2). These genes may
contain ZRE sequences that are more divergent from the
consensus. Alternatively, Zap1 may alter their expression
indirectly. It should be noted that ALD2 is closely related
to ALD3, which was found to be a potential Zap1 target
(Table 3). Therefore, ALD2 may have been detected due to
cross-hybridization with ALD3 mRNA in the microarray
experiments.
Identification of Zap1 targets induced by severe zinc 
deficiency
In our previous study, cells grown in the low zinc condi-
tions used in E1 and E2 experiments were cultured in CSD
medium from which zinc was removed with a metal-bind-
ing resin [3]. This medium was chosen to specifically pro-
vide a zinc-limiting condition without the use of strong
chelators that can bind other metal ions and alter their
availability. However, because chelators are not included
in CSD, this medium is not severely zinc limiting due toBMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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the presence of small amounts of contaminating zinc. We
reasoned that some Zap1 targets might require extremely
low zinc conditions, i.e. lower than that provided by CSD,
to be induced. Therefore, to search for additional Zap1
target genes, microarray experiments were performed with
RNA from cells grown in LZM, a low zinc medium con-
taining EDTA and citrate as metal buffers. Because of these
chelators, cells grown in LZM + 3 μM added ZnCl2 are
more zinc-limited than cells grown in CSD with no added
zinc. When comparing expression in cells grown in LZM +
3 μM ZnCl2 vs. LZM + 3 mM ZnCl2, 182 genes were up-
regulated ≥ 1.5-fold in duplicate arrays under this very low
zinc condition. We refer to this experiment as "E4." The
overlap between E3 and E4 was 67 genes (Fig. 1C). Of
these 67 genes, 50 contained ZRE-like sequences in their
promoters detectable by RSAT. Fifteen of these 50 genes
were not detected in the more mild E1/E2 growth condi-
tions suggesting that they are only induced under severe
zinc-limiting conditions. A list of these additional poten-
tial Zap1 target genes is provided in Table 3.
To summarize this analysis, we have obtained additional
evidence that 33 genes previously identified in our exper-
iments are Zap1 targets (Table 1). In addition, we have
identified a total of 31 new candidate Zap1 target genes
(Tables 2 and 3). The functions of many of these genes
and their possible relevance to zinc deficiency will be dis-
cussed later in this report.
Confirmation of microarray and RSAT results
To confirm the effects of zinc status and Zap1 mutations
on potential target gene expression, a subset of genes from
Tables 1, 2, 3 were selected for further analysis by S1
nuclease protection assay of RNA samples that were not
used for the microarray analysis. The known Zap1 target
ZRT1 and the constitutive calmodulin (CMD1) gene were
used as positive and negative controls, respectively (Fig.
2A). Four genes from Table 1 previously suggested to be
Zap1 targets (TKL2, PST1, YJL132W, ICY2) were tested
using cells grown under the same conditions as were used
for microarray experiments E3 and E4. The increased
expression of these genes in cells grown in low zinc or in
cells expressing the Zap1TC allele was confirmed by this
New strategies to identify genes regulated by Zap1 Figure 1
New strategies to identify genes regulated by Zap1. A) Identifying genes affected by moderate zinc deficiency. Experiments E1, E2, 
and E3 were combined to identify genes that showed increased expression in zinc-limited cells (E1), wild type cells vs. zap1Δ mutant cells 
in low zinc (E2), and Zap1TC-expressing cells in high zinc (E3). B) The ZRE sequences in the promoters of the previously identified 46 
Zap1 target genes [3] were aligned and a logo was built using WebLogo. C) Experiments E3 and E4 were combined to identify Zap1 tar-
gets that respond to severe zinc deficiency. Regulatory Sequence Analysis Tools (RSAT) was used to identify potential ZREs in the pro-
moters of co-regulated genes.BMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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Table 1: Confirmation of previously identified Zap1 target genes by E1, E2, and E3 clustering.
ORFa Gene Function Fold induction ZRE
E1b E2b E3-1c E3-2c startd scoree sequence
Experimentally tested Zap1 target genes
YDR284C DPP1 diacylglycerol pyrophosphate phosphatase 5.5 3.6 2.4 2.2 -452 9.6 ACCTGAAAGGT
YDR492W IZH1 membrane steroid hormone receptor ortholog 2.8 4.4 1.4 1.6 -914 5.0 TCCCTCAATGA
-417 11.2 ACCCTAAAGGT
YGL255W ZRT1 plasma membrane zinc uptake transporter 24.2 18.9 38.8 34.4 -456 9.3 ACCTTTGGGGT
-338 7.7 ACCTCGAAGGA
-319 12.0 ACCTTGAGGGT
-204 11.7 ACCTTGAAGGT
YGL256W ADH4 alcohol dehydrogenase IV 26.2 5.6 12.6 12.6 -269 9.4 ACCGTGAAGGT
-191 5.3 GCCTTCAATGA
YJL056C ZAP1 zinc-responsive transcriptional activator protein 7.5 16.9 96.5 79.7 -144 11.2 ACCCTAAAGGT
YKL175W ZRT3 vacuolar zinc export transporter 7.9 8.7 4.9 4.8 -155 11.6 ACCTTAAGGGT
YLR130C ZRT2 plasma membrane zinc uptake transporter 5.6 12.3 2.7 2.5 -941 6.1 ACCCTAACTGT
-311 11.2 ACCCTAAAGGT
-262 11.2 ACCCTAAAGGT
-174 5.8 ACCTTTTGGGA
-112 4.9 ACCAACAGGGT
-41 5.3 GCCTGCAATGT
YMR243C ZRC1 vacuolar zinc import transporter 2.1 4.7 1.6 1.8 -174 9.6 GCCTTGAAGGT
YMR319C FET4 plasma membrane Fe/Cu/Zn uptake transporter 2.3 2.4 1.6 1.7 -384 7.8 ACCCCACGGGT
YNR039C ZRG17 endoplasmic reticulum zinc import transporter 3.2 3.5 2.3 1.9 -527 11.7 ACCTTGAAGGT
YOL002C IZH2 membrane steroid hormone receptor ortholog 1.9 2.0 3.4 3.3 -256 7.7 ACCCTAGAGGA
-173 7.2 ACCCCGAGTGT
YOL154W ZPS1 cell wall protein, putative metalloprotease 13.9 10.1 78.6 57.9 -329 11.8 ACCTTCAGGGT
-314 11.8 ACCTTCAGGGT
Likely Zap1 target genes
YBL049W MOH1 zinc-binding protein, function unknown 10.7 2.2 3.2 3.8 -387 8.7 CCCTTGAGGGA
YBR117C* TKL2* transketolase, pentose phosphate pathway 5.4 2.0 1.9 2.1 -844 8.2 ACCTTATGGGT
-524 5.3 ACCCAAAATGT
YDR055W* PST1* cell wall protein 5.0 2.7 2.0 1.9 -886 7.4 ACCCCAAGGGA
-405 8.0 TCCTTGAGGGA
YGL121C GPG1 putative gamma subunit of a heterotrimeric G 
protein
10.8 2.7 2.1 2.4 -287 8.3 CCCTTCGAGGT
-208 9.0 ACCGTAAAGGT
YGL257C MNT2 mannosyltransferase, O-linked glycosylation 2.3 4.4 4.0 3.7 -572 5.3 GCCTTCAATGA
-494 9.4 ACCGTGAAGGT
YGL258W VEL1 function unknown 16.3 4.0 112.6 78.6 -763 6.3 ACCTTGCATGA
-232 10.4 ACCCTGCGGGT
YGR295C COS6 function unknown 2.7 2.2 1.5 1.6 -875 5.0 AACTTAAATGT
-309 9.1 ACCTTAAATGT
YJL132W* similar to phospholipase D 5.2 3.8 3.3 2.8 -154 7.8 ACCCAAAGGGT
YJR061W Mnn4-related, N-linked glycosylation 4.6 2.1 2.0 1.8 -278 9.8 ACCTTCAAGGA
YKL165C MCD4 glycosylphosphatidylinositol (GPI) anchor synthesis 4.1 2.5 1.8 1.8 -104 11.4 ACCTTAAAGGT
YLL020C function unknown 5.1 3.1 1.7 1.6 -933 12.0 ACCTTGAGGGT
YMR120C ADE17 AICAR transformylase, purine biosynthesis 5.2 3.7 1.9 2.2 -98 8.7 ACCTTTAGTGT
YMR271C URA10 orotate phosphoribosyltransferase, pyrimidine 
biosynthesis
6.1 2.5 4.9 5.2 -143 7.9 ACCTTTCGGGA
YMR297W PRC1 vacuolar carboxypeptidase Y 3.0 3.5 1.5 1.9 -182 8.1 ACCCCGCGGGT
YNL254C function unknown 9.7 12.0 2.3 2.0 -432 11.7 ACCTTGAAGGT
YNL336W COS1 function unknown 2.1 2.0 1.6 1.6 -871 5.0 AACTTAAATGT
-591 5.3 AACCTAGAGGT
-314 9.1 ACCTTAAATGT
YOL084W PHM7 major facilitator superfamily member, function 
unknown
9.7 2.1 2.5 2.3 -766 11.7 ACCTTGAAGGTBMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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analysis (Fig. 2B). Similarly, we tested 14 of the 31 new
candidate Zap1 target genes, i.e. 7 from Table 2 (Fig. 2C)
and 7 from Table 3 (Fig. 2D). The expression patterns of
all 14 of these genes were confirmed by S1 nuclease pro-
tection assay. These data indicate that we have discovered
several new genes directly regulated by Zap1.
YOL131W function unknown 5.0 2.3 2.5 2.2 -1000 7.6 AACTTCAGGGT
-458 8.2 ACCTGGAAGGA
-364 5.9 ACCCAAGAGGT
-122 5.5 TCCATTAGGGT
YOR387C function unknown 17.8 19.3 136.4 113.6 -763 6.3 ACCTTGCATGA
-231 10.4 ACCCTGCGGGT
YOR134W BAG7 GTPase-activating protein, control of cell wall 
synthesis
5.9 2.0 1.7 1.6 -445 6.0 CCCTCCAAGGA
-325 8.6 CCCCTGCAGGT
YPL250C* ICY2* function unknown 2.1 2.3 3.1 3.1 -756 8.9 CCCTTCCGGGT
-524 7.4 ACCCCAAGGGA
-475 5.7 GCCCAAAGGGT
-360 5.6 CCCGTCAGTGT
a) Results for genes marked with asterisks were confirmed independently by S1 nuclease protection assay in Figure 2.
b) Expression ratios are the average of two independent microarray experiments (Lyons et. al. 2000).
c) Results from two independent microarray experiments (E3-1 and E3-2) are shown.
d) Numbers indicate the distance from the ATG initiation codon.
e) Score calculated for each sequence with a position-specific scoring matrix generated by RSAT.
Table 1: Confirmation of previously identified Zap1 target genes by E1, E2, and E3 clustering. (Continued)
Table 2: New candidate Zap1 target genes identified by E1, E2, and E3 clustering.
ORFa Gene Function Fold induction ZRE
E1b E2b E3-1c E3-2c startd scoree sequencef
YBL029W function unknown 3.0 2.9 1.6 1.4 -995 5.8 CCCCTGCCGGT
YBR072W* HSP26* small heat shock protein, protein folding 40.5 2.0 3.3 3.5 -451 5.3 ACCTTGCCTGT
YDR077W* SED1* cell wall protein 2.6 2.2 2.6 2.1 -896 4.7 CCCTTATAGGA
YGR088W* CTT1* catalase T, oxidative stress resistance 17.1 3.7 1.9 1.7 -337 5.7 CCCTTACCGGT
YGR243W FMP43 mitochondrial protein, function unknown 2.8 2.7 3.1 2.5 -552 4.9 TCCTCGAATGT
YHR214W-A function unknown 6.5 2.6 3.0 3.2 -274 4.8 ACCTCTGGTGT
YIL045W PIG2 putative protein phosphatase regulatory subunit 4.6 2.4 1.6 1.5 -859 4.7 ACCTTCCACGT
YJL048C* UBX6* UBX (ubiquitin regulatory X) domain-containing 
protein
2.3 3.3 1.8 1.6 -198 5.2 TCCATTAAGGT
-39 5.9 CCCTCAAAGGA
YKR046C PET10 lipid particle protein, unknown function 2.9 3.0 1.7 1.7 -929 4.8 ATCTTGCAGGT
YLR136C* TIS11* tristetraproline homolog, control of mRNA 
stability
2.6 4.1 5.6 3.7 -821 4.9 GCCCGTGAGGT
-768 6.3 AACCTGCGGGT
-507 6.0 GCCCAGAGGGT
YML028W TSA1 peroxiredoxin, oxidative stress resistance 5.0 2.9 2.0 1.5 -195 5.5 GCCCGTCGGGT
-170 7.2 TCCCTAAAGGA
YMR181C function unknown 5.9 2.2 2.6 2.7 -237 5.1 CCCTTCGAGGG
YNL239W* LAP3* homocysteine thiolactonase 2.1 4.7 2.9 2.9 -947 4.8 GCCTCCAATGT
YOL082W ATG19 autophagy and cytoplasm-to-vacuole (CVT) 
targeting pathway
4.3 3.2 1.6 1.4 -281 5.9 ACCTTAAAAGT
-998 4.9 ACCAACAGGGT
YOL155C* cell wall protein 11.8 3.5 2.3 2.9 -361 6.3 ACCGTGCAGGA
YPL159C PET20 mitochondrial protein required for respiratory 
growth
9.1 5.2 4.5 4.0 -278 5.3 GCCATTAAGGT
-180 5.6 ACCCTTTGGGA
a) Results for genes marked with asterisks were confirmed independently by S1 nuclease protection assay in Figure 2.
b) Expression ratios are the average of two independent microarray experiments (Lyons et. al. 2000).
c) Results from two independent microarray experiments (E3-1 and E3-2) are shown.
d) Numbers indicate the distance from the ATG initiation codon.
e) Score calculated for each sequence with a position-specific scoring matrix generated by RSAT.
f) ZREs shown in bold were tested for interaction with Zap1 as described in Figure 3A.BMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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The RSAT algorithm identified several potential ZREs in
addition to those recognized by MEME. Many of these
sequences had low RSAT scores near the minimum cut-off
value of 4.5 and were very divergent from the consensus
ZRE sequence (ACCTTNAAGGT, RSAT score = 11.7) (Fig.
1B). To determine if Zap1 can bind to these candidate
ZREs in a sequence-specific manner, we performed elec-
trophoretic mobility shift assays (EMSA) (Fig. 3A). The
Zap1 DNA binding domain (Zap1DBD, residues 687–880)
was purified from E. coli and used in these in vitro experi-
ments. Double-stranded oligonucleotides were end-
labeled with 32P, mixed with the purified Zap1DBD, and
then fractionated by non-denaturing polyacrylamide gel
electrophoresis. Binding of Zap1DBD  to the previously
characterized TSA1 ZRE (RSAT score = 5.5) served as a
positive control (Fig. 3A, lane 2). Zap1DBD was unable to
bind to a TSA1 ZRE that had been mutagenized at each of
its 11 base pair positions by transversion mutations (Fig.
3A, lane 3). This mutant ZRE was previously shown to be
nonfunctional in vivo [23]. Zap1DBD binding was detected
with all of the candidate ZREs tested. These sequences
ranged in RSAT scores from a low of 4.7 (SAM3, SED1) to
a high of 6.9 (HNT1). The ability of Zap1DBD to bind to
these sequences in vitro suggests that they may be func-
tional binding sites in vivo.
Additional evidence that the identified ZREs are func-
tional in vivo came from an analysis of the distribution of
these sequences within the promoter regions of candidate
Zap1 target genes. As shown in Fig. 3B, when the position
of the RSAT-predicted ZREs were mapped relative to the
open reading frame of each gene, a clear bias was appar-
ent; most of these sequences were found between 100 and
500 base pairs upstream. This distribution correlates well
with the position of regulatory elements in other yeast
promoters [24]. Chi-square analysis indicated that this
distribution of ZRE sequences was not random (P <
0.001). As an additional control, we identified 156 ZRE-
like sequences in the promoters of yeast genes that do not
show Zap1-dependent regulation and are therefore
unlikely to be functional Zap1 binding sites (see Materials
and Methods). The locations of these nonfunctional
sequences were consistent with a random pattern of distri-
bution (P > 0.05). Taken together, these results suggest
that RSAT is a sensitive method to detect regulatory motifs
among the promoters of co-regulated genes that are likely
to be functional.
Differential regulation of Zap1 target genes
To characterize how Zap1 target genes respond to a range
of zinc availability, we performed additional microarray
experiments in which we assayed their expression in wild
Table 3: New candidate Zap1 target genes identified by E3 and E4 clustering.
ORFa Gene Function Fold inductionb ZRE
E3-1 E3-2 E4-1 E4-2 startc scored sequencee
YDL125C* HNT1* adenosine 5'-monophosphoramidase 1.9 1.6 3.6 4.1 -279 6.9 GCCTCAAAGGT
YEL060C* PRB1* vacuolar proteinase B 2.6 2.8 2.0 2.1 -677 6.5 GCCATGAGGGT
YFL014W HSP12 cell wall protein, stress resistance 1.5 1.5 4.4 3.7 -211 5.0 ACCTCAAAGTT
YGR254W ENO1 enolase I, glycolysis and gluconeogenesis 2.6 2.9 1.4 1.7 -927 9.4 ACCGTGAAGGT
-371 5.1 ACCTGAGCGGT
-216 5.6 CACCTCAAGGT
YGR279C* SCW4* cell wall protein with similarity to glucanases 1.8 1.9 1.5 1.4 -481 5.4 CCCTGCACGGT
-466 6.3 ACCCTCTGGGA
YHR174W* ENO2* enolase II, glycolysis and gluconeogenesis 2.5 2.8 1.3 1.6 -594 4.8 ACGCTGCGGGT
YIL169C* cell wall potein 3.4 3.1 2.1 2.2 -742 10.8 ACCCGGAAGGT
-252 6.0 ACCTCGCAGGC
YJL052W TDH1 glyceraldehyde-3-phosphate dehydrogenase 1.4 1.6 1.6 1.6 -347 4.6 ACCTTCGGAGT
YJL171C cell wall protein 1.6 1.8 1.6 1.8 -573 4.9 CCCATAAAGGA
YKR042W* UTH1* mitochondrial protein, oxidative stress resistance 3.5 4.0 1.4 1.5 -282 6.9 CCCTTCAATGT
YLL053C aquaporin 1.6 1.5 1.7 1.5 -354 5.5 ACCGGTCGGGT
YMR169C ALD3 aldehyde dehydrogenase 2.0 1.9 1.6 1.5 -214 9.1 TCCCTAAGGGT
-79 4.6 ACCTGGCATGA
YOR348C PUT4 proline permease 1.8 1.8 1.9 1.8 -299 8.2 CCCTGCAAGGT
YPL274W* SAM3* S-adenosylmethionine permease 1.9 1.7 2.1 2.2 -240 4.7 TCCCCTGCGGT
YPR003C putative ER sulfate permease 2.2 2.1 1.5 1.5 -149 5.5 ACCGAAAAGGT
a) Results for genes marked with asterisks were confirmed independently by S1 nuclease protection assay in Figure 2.
b) Results from two independent microarray experiments (E3-1, E3-2; E4-1, E4-2) for each condition are shown.
c) Numbers indicate the distance from the ATG initiation codon.
d) Score calculated for each sequence with a position-specific scoring matrix generated by RSAT.
e) ZREs shown in bold were tested for interaction with Zap1 as described in Figure 3A.BMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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type cells grown for 16 hours in batch cultures supple-
mented with various concentrations (i.e. 3, 10, 30, 100, or
300 μM) of zinc. RNA from cells grown in LZM + 3 mM
ZnCl2 was used as the zinc-replete control for each of
these comparisons and the data obtained are plotted in
Fig. 4A (left panel). A narrow color scale was chosen for
this panel to highlight the conditions under which detect-
able increases in gene expression occurred. Because this
scale obscures the results obtained for the most highly
induced genes (e.g. ZRT1, YOR387C), data for several
genes are also plotted in Fig. 4B using a broader scale that
allows for comparison of the expression levels across the
full range of zinc conditions.  The numerical data from the
experiments shown in Figure 4 are provided in Additional
file 5.
From this dose-response analysis, it was apparent that
Zap1 target genes show extremely varied responses to zinc
deficiency. Some genes, such as ZRT1, FET4, ZPS1, and
YOR387C responded to very mild conditions of zinc defi-
ciency (i.e. LZM + 300 μM ZnCl2) while the ZRT3 and
IZH2 genes were induced by moderate conditions of zinc
deficiency (LZM + 100 or 30 μM ZnCl2). In contrast, most
Zap1 target genes only responded to more severe defi-
ciency conditions (LZM + 10 or 3 μM ZnCl2). Among
these was ADH4 whose induction by low zinc correlated
closely with the Zap1-mediated repression of the ADH1
and ADH3 genes. Also among the genes only responding
to severe zinc limitation were ZRG17 and TSA1, i.e. genes
likely to be involved in adaptation to zinc-limiting condi-
tions (see Discussion).
Other patterns of expression were also observed. For
example, induction of ZRT2 was observed in response to
mild deficiency (LZM + 300 μM ZnCl2) and its repression
by Zap1 was readily apparent in cells grown in LZM + 10
or 3 μM ZnCl2. No other Zap1 targets showed clear evi-
dence for a similar combination of Zap1 induction and
repression with the possible exceptions of IZH2 and PEP4.
In contrast, several other genes (i.e. MCD4, UBX6, ICY2,
HNT1, URA10) showed decreased expression under mild-
to-moderate zinc deficiency but showed increased expres-
sion in severely zinc-limited cells. This profile may reflect
Figure 2
Confirmation of the microarray results for potential Zap1  target genes Figure 2
Confirmation of the microarray results for potential Zap1 
target genes. S1 nuclease protection assays were performed 
using RNA isolated from cells grown under the same conditions as 
microarray experiments E3 and E4. A) ZRT1 and CMD1 were used 
as positive and loading controls, respectively. Results with candi-
date genes from Table 1 (B), Table 2 (C) and Table 3 (D) are 
shown. The band intensities were quantified and normalized to 
CMD1 levels, and the fold increase in E3 and E4 conditions is 
reported. These data confirmed the microarray results for these 
genes.BMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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the loss of activity of other transcription factors during
moderate zinc deficiency that was compensated by up-
regulation by Zap1 in severely zinc-limited cells.
Regulation of Zap1 target genes was also assessed over
time in cells undergoing zinc withdrawal. Wild type cells
were transferred from a zinc-replete medium (LZM + 1
mM ZnCl2) to a severely zinc-limiting condition (LZM + 1
μM ZnCl2) and gene expression was monitored over an 8-
hour period. We predicted that genes that respond to mild
zinc deficiency under the more steady-state conditions of
batch culturing would also respond quickly to the mild
zinc deficiency that would occur shortly after zinc with-
drawal commenced. Consistent with this expectation, sev-
eral genes induced by mild or moderate zinc deficiency
(e.g. ZRT1, ZPS1, YOR387C, ZRT3) were induced shortly
(i.e. within 1 hour) after transition from high to low zinc
(Fig. 4A, right panel). Similarly, genes that responded only
to severe deficiency in batch culture usually required
much longer periods of zinc withdrawal (8 hours) for
induction to be observed. Many of these genes decreased
in expression level soon after transition to zinc-limiting
conditions and, in some cases, were not increased relative
to zinc-replete cells even after 8 hours in zinc-limiting
medium. Induction was apparent after 16 hours in zinc-
limiting conditions (dose-response analysis, Fig. 4A, left
panel) suggesting that these genes require more than 8
hours of zinc withdrawal for their mRNA levels to
increase.
The results in Fig. 4 indicated that there is generally a good
correlation between the severity of the zinc deficiency
required for induction of a Zap1 target gene under steady
state conditions and its timing of induction following zinc
withdrawal. However, some striking exceptions to this
correlation were observed. For example, while FET4 and
ZRT2 responded to mild zinc deficiency, they responded
only slowly to zinc withdrawal. Conversely, while ICY2
responded only to severe zinc deficiency, it was highly
induced within 30 minutes of zinc withdrawal. The
underlying mechanisms and physiological significance of
these intriguing differences in expression patterns are
unclear.
One possible mechanism underlying differential Zap1 
target gene expression
The data in Figure 4 indicate that some Zap1 target genes
respond to mild zinc deficiency while others respond only
to severe deficiency. While many factors may contribute to
these patterns of expression, one simple hypothesis is that
the quality of ZREs within a gene's promoter determines
its expression pattern. Specifically, genes with ZREs
closely matching the Zap1 consensus sequence would
respond to mild zinc deficiency because Zap1 could bind
Evidence that ZRE sequences identified by RSAT are functional Zap1 binding sites Figure 3
Evidence that ZRE sequences identified by RSAT are functional Zap1 binding sites. A) Electrophoretic mobility shift assay of 
candidate ZREs. Radiolabeled double-stranded oligonucleotides (0.5 pmol, 10,000 cpm) containing potential ZRE sequences from the indi-
cated promoters were used as probes. The probes were mixed with 0 (-), 0.2 (±), 0.4 (+), or 0.8 (‡) μg per reaction of purified Zap1 
DNA binding domain (Zap1DBD). The arrow indicates the Zap1DBD-DNA complex. The bona fide ZRE from TSA1 was used as a positive 
control and a mutant nonfunctional allele of that sequence (TSA1m) was used as a negative control. B) Nonrandom distribution of ZRE-
like sequences in candidate Zap1 target gene promoters. In the upper panel, the positions of ZRE-like sequences in candidate Zap1 target 
promoters are plotted relative to the distance from the ATG start codon of the corresponding ORF. In the lower panel, the positions of 
ZRE-like sequences identified in the promoters of genes not showing zinc- and/or Zap1-responsive gene expression are plotted.BMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
Page 10 of 17
(page number not for citation purposes)
Figure 4BMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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to those high affinity sites under those conditions when
Zap1 levels are low. To activate promoters with weaker
binding sites, the increased expression of Zap1 that occurs
in zinc-limited cells would be required. This concept is
similar to the differential binding of Zap1 to the ZREs
found in the ZRT2 promoter [17]. Consistent with this
hypothesis, we observed that the ZREs found in genes
induced by mild deficiency (ZRT1, ZRT2, ZPS1, etc.) more
closely match the consensus sequence (average RSAT
score = 10.0) than do ZREs from genes that respond only
to severe deficiency (average RSAT score = 7.1). This differ-
ence was even more striking when all of the ZREs were
divided into quartiles based on RSAT score and the per-
centage of ZREs in each quartile were plotted. While ZREs
among genes responding to only severe zinc limitation
showed a fairly even distribution among quartiles, ZREs
from genes responding to mild deficiency showed a clear
bias toward the highest quartile (9.2–12.0) of RSAT scores
(Fig. 5). Chi-square analysis confirmed that these are sta-
tistically significant differences (P < 0.001). No significant
differences in the number of ZREs per promoter or the dis-
tances of the ZREs from the open reading frame were
observed between the two sets of genes. Thus, we suggest
that ZRE affinity may play a major role in dictating expres-
sion patterns observed among Zap1 target genes. It should
be noted, however, that there are clear exceptions to this
rule. For example, the ZRG17 promoter has a high affinity
ZRE that exactly matches the consensus sequence but this
gene only responds to severe deficiency. Other factors,
such as chromatin structure, may influence binding of
Zap1 to the ZRG17 promoter.
Discussion
Zinc deficiency causes drastic changes in yeast gene
expression. We previously reported that ~15% (934) of all
yeast genes increased or decreased in expression in zinc-
limited vs. zinc-replete yeast grown in batch cultures [3].
Similarly, De Nicola et al. reported that 381 genes were
affected by zinc status in chemostat cultures [12]. Because
zinc plays so many functional roles, the majority of these
effects are likely to be indirect responses to changes in cel-
lular processes resulting from decreased activity of key
zinc-dependent proteins. To define the direct responses to
zinc deficiency, we are identifying genes under the control
of the Zap1 transcription factor. In this way, we can learn
how cells respond specifically to the stress of zinc-limiting
conditions.
We previously used a combination of microarray analysis
and a motif identification algorithm to identify 46 poten-
tial Zap1 targets [3]. In this current study, we made impor-
tant modifications to our previous approach by using
Differences in ZREs among Zap1 target genes Figure 5
Differences in ZREs among Zap1 target genes. All ZREs 
from genes that respond to mild zinc deficiency and those that 
respond only to severe deficiency were divided into quartiles 
based on their RSAT scores. In the upper panel, the percentage of 
ZREs in each quartile for the genes responding to mild zinc defi-
ciency are plotted. In the lower panel, the percentage of ZREs in 
each quartile for the genes responding to severe zinc deficiency 
are plotted. Chi-square analysis indicated that the different distri-
butions among quartiles obtained with the two sets of ZREs are 
significant (P < 0.001).
Differential regulation of Zap1 target genes in response to zinc Figure 4
Differential regulation of Zap1 target genes in response to zinc. A) Microarray studies were performed with cells grown over a 
range of zinc (left panel) or over time after zinc withdrawal (right panel). For the dose-response analysis, cells were grown in LZM + 3 mM 
ZnCl2, or LZM + 300, 100, 30, 10 or 3 μM ZnCl2. Transcript levels were assayed using microarrays in which each sample was paired with 
the zinc-replete (LZM + 3 mM ZnCl2) control. For the time-course studies, cells were grown to exponential phase in a zinc-replete 
medium (LZM + 1 mM ZnCl2) and then transferred to a zinc-limiting medium (LZM + 1 μM ZnCl2) for 8 hours. RNA was isolated at the 
indicated times and transcript levels were assayed using microarrays in which each sample was paired with the zinc-replete To control. 
Genes were grouped by related function and the results are displayed using the Java Treeview program http://jtreeview.sourceforge.net. 
A narrow color intensity scale (yellow, increased expression relative to control; blue decreased expression) is used to show the conditions 
under which changes in gene expression were first detectable. B) The data for highly expressed genes in panel A were plotted with a 
broader scale to better show the differences in gene expression. The complete dose-response and time-course analyses were performed 
twice with similar results and the data, presented as the ratio relative to control, are provided in Additional file 5.BMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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alternative growth conditions for the microarray experi-
ments and a different motif analysis algorithm that was
better able to detect potential Zap1 binding sites. Using
these new tools, we have extended many aspects of our
previous work. First, this study provides additional confir-
mation for many genes previously proposed to be Zap1
targets (Table 1). For example, genes such as MOH1,
TKL2, etc. were suggested to be direct Zap1 targets based
on their Zap1-dependent induction in zinc-limited cells
[3]. Their increased expression in cells expressing the
Zap1TC allele provides strong additional support for this
hypothesis. In all, 33 of our original 46 potential targets
were confirmed in this way. Several of the remaining 13
genes (e.g. YBL048W,  COS4,  COS8, RAD27) showed
increased expression in Zap1TC-expressing cells although
these effects did not meet our minimum cut-off value of
1.5-fold changes (Additional file 1).
In addition, we have added 31 potential new members to
the Zap1 regulon. Sixteen of these genes were observed in
our previous study to be zinc-responsive and Zap1-
dependent [3] but were not considered to be direct Zap1
targets because we were unable to identify potential ZREs
in their promoters using MEME (Table 2). With RSAT, we
identified their potential ZREs and went on to show that
many of these sequences were specifically bound by Zap1
in vitro. The response of these genes to the Zap1TC allele
also provides additional evidence for their direct regula-
tion by Zap1. The other 15 new target genes responded to
more severe zinc-limiting conditions than that used in our
previous study (Table 3). These genes, plus four addi-
tional genes identified as Zap1 targets using other meth-
ods, i.e. EKI1, PIS1, ZRR1, and ZRR2 [18,21,22], brings
the total of confirmed and potential Zap1 targets in the
yeast genome to 81 genes.
With the identification of many new targets of Zap1 acti-
vation, we are building a comprehensive picture of how
yeast cells respond to zinc-limiting conditions. A sum-
mary of the functional roles of many of these genes is pro-
vided in Table 4 and a figure showing the general
relationship of these genes to their response over a range
of zinc levels is provided in Fig. 6. We can separate these
responses conceptually into first- and second-lines of
defense against the stress of zinc deficiency. The first-line
defense genes play key roles in zinc homeostasis while
many second-line defense genes allow the cells to adapt to
zinc-limiting conditions when they can no longer obtain
sufficient zinc for optimal growth. One caveat to this anal-
ysis is that we are assuming that changes in transcript lev-
els are accompanied by similar changes in protein
abundance and this assumption is not necessarily true.
Nonetheless, the following discussion provides a clear
and testable framework for understanding the cellular
responses to zinc deficiency.
Among the first-line defense genes, ZRT1, ZRT2, and FET4
are induced by mild zinc deficiency to increase the ability
Table 4: Functional categories of genes regulated by the Zap1 transcriptional factor.
Functional Group Zap1 Target Genes
First-line defenses: Zinc homeostasis
Zinc uptake ZRT1, ZRT2, FET4, ZPS1
Mobilize zinc stores ZRT3
Increase transcription response ZAP1
Zinc sparing ZRR1 (ADH1), ZRR2 (ADH3), ADH4
Zinc shock resistance ZRC1
Other zinc homeostasis genes IZH1, IZH2
Second-line defenses: Adaptive responses
Secretory pathway function ZRG17, MNT2, MCD4, YJR061W
Cell wall function PST1, BAG7, HSP12, SED1, SCW4, YOL155C, YIL169C, YJL171C
Stress resistance GRE2, RAD27, TSA1, CTT1, UTH1, HSP26
Phospholipid metabolism DPP1, EKI1, PIS1, YJL132W
Sulfur metabolism LAP3, SAM3, YPR003C
Protein degradation PRC1, PEP4, PRB1, ATG19, UBX6
Carbohydrate metabolism NRG2, TKL2, ENO1, ENO2, TDH1
Purine/pyrimidine metabolism URA10, ADE17, HNT1
Mitochondrial function FMP43, PET20, PET10
Other VEL1, MOH1, GPG1, COS6, ICY2, COS1, PHM7, PIG2, TIS11, ALD3, PUT4, COS2, ZIP1, COS4, COS8, 
TPO5, COS3, YNL254C, YOR387C, YLL020C, YOL131W, YBL029W, YHR214W-A, YMR181C, YLL053C 
, YBL048C, YMR086W, YNL234W
Genes shown in bold are new targets in this studyBMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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of the cell to accumulate zinc from its environment. ZPS1
is also induced under these mild conditions and we have
previously proposed that its product, a secreted protein
related to metalloproteases, may also be involved in zinc
acquisition by degrading extracellular proteins and releas-
ing any bound metals [3]. Similarly, ZRT3 is up-regulated
by mild zinc deficiency and also responds rapidly to zinc
withdrawal. Thus, mobilization of zinc stores from the
vacuole is also a first-line response. Induction of the
YOR387C gene in response to mild zinc deficiency sug-
gests that this gene is also involved in the first-line defense
against zinc limitation. The function of this protein is not
yet known but its pattern of regulation by zinc suggests
that it may play a role in zinc uptake or vacuolar zinc
export. TIS11 (also known as CTH2) is also induced in
LZM + 300 μM ZnCl2. Tis11 binds to specific mRNAs and
signals their degradation in response to iron limitation
[25]; its role in zinc deficiency is not yet determined.
Other first-line defenses to zinc deficiency include an
increase in ZAP1 expression mediated by Zap1 autoregu-
lation [1]. The resulting increase in Zap1 protein level may
maximize target gene expression and is also likely to be
responsible for repression of ZRT2 under these conditions
[17]. In support of this latter hypothesis, we note that
ZRT2 repression correlates well with the observed increase
in ZAP1 mRNA levels. In addition, the coordinated switch
from ADH1/ADH3 expression to ADH4 expression likely
represents a mechanism to conserve zinc for other uses
[18]. Finally, we observed an increase in ZRC1 expression
in moderate-to-severely zinc-deficient cells. We showed
previously that this induction is required for cells to sur-
vive the stress of zinc shock, i.e. when zinc-deficient cells
are re-supplied with zinc [26]. The high activity of zinc
uptake transporters in these cells results in rapid zinc over-
load and the increased activity of Zrc1 is needed to seques-
ter the excess zinc in the vacuole.
Induction of many Zap1 target genes occurred only in
response to the most severe zinc-limiting condition we
tested (LZM + 3 μM ZnCl2) and only slowly in response to
zinc withdrawal. We consider these genes to be the second
line of defense against zinc deficiency. Most of these sec-
ond-line defense genes appear to be involved in the adap-
tation to zinc deficiency rather than playing a role in zinc
homeostasis (see below). This transition from homeo-
static to adaptive mechanisms correlates well with what
we know about cell growth under these conditions. We
previously showed that cells grow at their maximum
growth rate in LZM supplemented with ≥ 10 μM ZnCl2 but
their growth rate decreases in media containing less zinc
[14]. Thus, under conditions that induce the second-line
defense genes, zinc homeostatic mechanisms are no
longer capable of supplying sufficient zinc for optimal
function of cellular processes. Our results indicate that it
The relationship between gene function and regulation by Zap1 in response to zinc status Figure 6
The relationship between gene function and regulation by Zap1 in response to zinc status. The top line indicates the range 
of zinc levels in our experiments ranging from mild (LZM + 300 μM ZnCl2) to severe (LZM + 3 μM ZnCl2) zinc deficiency. The bars 
below indicate the range of zinc over which each functional response occurs. Sample data from Figure 4A are included to illustrate the 
patterns of differential regulation for genes from different functional categories. See Table 4 for details regarding the various adaptive 
responses and the particular genes associated with both homeostatic and adaptive responses.BMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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is under these conditions of suboptimal zinc that adaptive
responses occur.
One important functional category of second-line defense
involves secretory pathway function (Table 4). The ZRG17
zinc transporter gene is up-regulated presumably to main-
tain the zinc status of the endoplasmic reticulum [27,28].
MCD4 and MNT2 encode enzymes required for protein
modifications (GPI anchor synthesis and O-linked glyco-
sylation), that occur in the ER and the Golgi, respectively
[29,30]. YJR061W encodes an ER-localized protein [31]
related to Mnn4, which is involved in both N- and O-
linked glycosylation [32]. Increased expression of these
proteins may help maintain the efficiency of these proc-
esses under the adverse conditions of severe zinc defi-
ciency. Consistent with this hypothesis, Mcd4 is thought
to be a zinc-dependent enzyme [33].
Another group of second-line defense genes are involved
in cell wall function (Table 4). These include PST1,
HSP12, SED1, and SCW4. While their specific functions
are unclear, these proteins all reside in the cell wall sug-
gesting that cell wall remodeling occurs under zinc-limit-
ing conditions. These alterations may be important to
maintain the structural integrity of the cell wall. Consist-
ent with this hypothesis, disruption of zinc transport into
the secretory pathway caused increased sensitivity to an
inhibitor of cell wall function, calcofluor white [34]. This
observation suggests that defects in cell wall synthesis
occur in zinc-limited cells.
A third functional category of second-line defense genes
are involved in stress resistance (Table 4). Our results
implicate TSA1, CTT1, UTH1, and HSP26 as Zap1 targets
along with previously identified targets RAD27 and GRE2.
RAD27 encodes a nuclease that is required for the stability
of minisatellite repeats in genomic DNA [35,36]. The
recent observation that zinc deficiency in yeast destabi-
lizes these DNA repeats [37] is consistent with a role of
Rad27 in promoting genome stability in zinc-limited
cells. GRE2 encodes a methylglyoxal reductase [38]. Meth-
ylglyoxal is a byproduct of glycolysis that can react with
proteins to disrupt their function [39]. We note with inter-
est that two major targets of damage by methylglyoxal, the
enolases encoded by ENO1 and ENO2 [39], are also up-
regulated by Zap1 (Table 3). TSA1, CTT1, and UTH1 are
involved in resistance of the cell to oxidative stress. We
recently showed that yeast cells grown under severe zinc-
limiting conditions experience increased oxidative stress
[23]. In addition, we demonstrated that induction of
TSA1, encoding the major cytosolic peroxiredoxin, in low
zinc is required to resist that increased stress. CTT1,
encoding the cytosolic form of catalase [40], may be up-
regulated for similar reasons. Uth1 is a mitochondrial
protein of unknown function that is required for superox-
ide resistance [41] so its induction by Zap1 may also be
related to oxidative stress resistance. Lastly, Hsp26 is a
member of the small heat shock protein family that has
chaperone activity and protects proteins from misfolding
[42]. The regulation of these genes by Zap1 may help tem-
per the various stresses experienced by zinc-limited cells.
Other functional categories of Zap1 target genes induced
by severe zinc deficiency include phospholipid synthesis,
protein degradation, and carbohydrate, sulfur, and
purine/pyrimidine metabolism (Table 4). On a final note,
more than half of the genes now identified as potential
Zap1 targets (47 of 81) have mammalian orthologs. Reg-
ulating the expression of these genes may also be impor-
tant for cell growth under low zinc conditions in
mammals.
Conclusion
In this report, we have identified 31 new potential targets
of Zap1 and have characterized the response of these and
previously identified target genes to changes in zinc status
and to time following zinc withdrawal. This analysis of
Zap1 transcriptional regulation is providing unexpected
and exciting new insights into the mechanisms of metal
nutrient homeostasis in yeast and is telling us much about
how these cells adapt to growth under the stress of zinc
deficiency. Future studies will address the detailed roles of
these various adaptive responses to cell growth under
zinc-limiting conditions.
Methods
Growth conditions and strains
Yeast cells were grown in YPD (YP medium + 2% glucose)
and in synthetic defined SD medium with 2% glucose or
2% galactose and any necessary auxotrophic require-
ments. YPD and SD are zinc-replete media because they
contain micromolar levels of zinc and lack strong zinc
chelators. Yeast were made zinc limited by culturing in
low zinc medium (LZM) prepared as previously described
[43]. LZM is zinc limiting because it contains 1 mM EDTA
and 20 mM citrate to buffer metal availability. Therefore,
only a small fraction of the total zinc in LZM medium is
available for uptake by cells. Zinc was added to LZM as
ZnCl2. The wild type strain DY1457 (Matα ade6 can1 his3
leu2 trp1 ura3) was used in all experiments.
Microarray analysis
The data for Experiment 1 (E1) and Experiment 2 (E2) are
from Lyons et al. [3]. The new microarray analyses used
cells grown under two different paired conditions and
each experiment was performed in duplicate with inde-
pendent cultures. In Experiment 3 (E3), wild type
(DY1457) cells were transformed with the vector (pYef2)
or a plasmid (pYef2-Zap1TC) encoding a constitutive allele
of Zap1 under the regulation of the galactose-inducible
GAL1  promoter. The plasmid pYef2 and pYef2-Zap1TCBMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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constructs were previously described [7]. These transform-
ants were inoculated into zinc-replete SD medium + 2%
galactose + 1 μM ZnCl2 and grown for 20–24 h before har-
vesting at an optical density measured at 600 nm (OD600)
of ~0.8. In Experiment 4 (E4), wild type (DY1457) cells
were grown in a severely zinc-limiting medium (LZM + 3
μM ZnCl2) and in a zinc-replete medium (LZM + 3 mM
ZnCl2) for 14–16 hours and harvested at an OD600 of
~0.7. For the dose-response analysis, wild type (DY1457)
cells were grown in LZM + 3 mM ZnCl2, or LZM + 300,
100, 30, 10 or 3 μM ZnCl2. Transcript levels were assayed
using microarrays in which each sample was paired with
the zinc-replete (LZM + 3 mM ZnCl2) control. For the
time-course studies, wild type (DY1457) cells were grown
to exponential phase in a zinc-replete medium (LZM + 1
mM ZnCl2), washed twice in LZM with no added zinc,
and then transferred to a zinc-limiting medium (LZM + 1
μM ZnCl2) for 8 hours. Transcript levels were assayed
using microarrays in which each sample was paired with
the zinc-replete To control. These experiments were also
performed in duplicate with independent cultures. Total
RNA was extracted from cells grown as described above
with hot phenol and mRNA was isolated from total RNA
using the PolyATtract mRNA Isolation System IV kit
(Promega). Cy3-dUTP or Cy5-dUTP was incorporated
during reverse transcription of the polyadenylated RNA
[44]. The fluorescently labeled products were recovered
and hybridized to yeast whole-genome microarrays,
washed, and scanned as previously described [44].
To remove intensity-dependent measurement artifacts, we
normalized the log Cy3/Cy5 fold changes within each
microarray slide using the locally weighted scatterplot
smoothing (LOWESS) algorithm [45]. Genes exhibiting
sufficiently high fold change were screened for subse-
quent analysis. We chose an arbitrary cut-off value of a
fold change ≥ 1.5 based on the average of two independ-
ent microarrays with the provision that both arrays
showed a fold change of at least 1.4. One gene, ENO2, did
not fully satisfy these criteria but was selected for further
analysis because of the presence of a potential ZRE in its
promoter. Subsequent S1 nuclease protection assays con-
firmed the zinc- and Zap1-responsive regulation of ENO2.
Promoter motif and ZRE distribution analysis
The ZREs in the promoters of the 46 potential Zap1 targets
previously identified with the Multiple Expectation Maxi-
mization for Motif Elicitation (MEME) program (please
see Availability & requirements for more information)
[46] were used to generate a position-specific probability
matrix with Regulatory Sequence Analysis Tools (RSAT –
please see Availability & requirements for more informa-
tion)[47]. Potential ZREs in the promoters (nucleotide
positions -1000 to +1 where +1 is the first base of the ATG
start codon) of zinc- and Zap1-responsive genes were then
identified using this matrix and RSAT. To assess the distri-
bution of potential ZREs in promoter regions, PatMatch
(please see Availability & requirements for more informa-
tion) was used to identify ZRE-like sequences in the pro-
moters of other yeast genes using the input sequence of
ACCYKNRRKGT (Y = C or T, K = G or T, R = A or G, N =
any base). 138 genes were identified that contain one or
more copies of this sequence in their promoters but were
not zinc- and Zap1-responsive; 156 total ZRE-like
sequences were found in these promoters. The random-
ness of distribution of these sequences was assessed using
the chi-square test. WebLogo (please see Availability &
requirements for more information) [48] was used to gen-
erate the graphical representation of the ZRE consensus
sequence shown in Figure 1B. To determine if the RSAT
scores of ZREs in promoters that respond to mild defi-
ciency were significantly different from those in promot-
ers that respond only to severe deficiency, the total
number of ZREs were divided into equal quartiles and
then the ZREs in the two sets were divided among those
quartiles. The chi-square test was then used to determine
if the distribution of scores between those sets was statis-
tically significant.
RNA analysis
S1 nuclease protection assays were performed with total
RNA as described [49]. The oligonucleotide probes used
for these experiments are described in Additional file 3.
For each reaction, 15 μg of total RNA was hybridized to
32P-end-labeled DNA oligonucleotide probes before
digestion with S1 nuclease and separation on a 10% poly-
acrylamide, 5 M urea polyacrylamide gel. Band intensities
were quantitated by PhosphorImager analysis (Perk-
inElmer, Inc.).
Electrophoretic mobility shift assays
The Zap1 DNA binding domain (Zap1DBD, residues
687–880) was expressed in E. coli as a fusion to glutath-
ione S-transferase, purified, and then the glutathione S-
transferase tag was removed with thrombin as previously
described [5]. Electrophoretic mobility shift assays were
performed as previously described using purified Zap1DBD
protein and radiolabeled ZRE oligonucleotides (Addi-
tional file 4). Briefly, 15 μl reactions were prepared con-
taining 0.5 pmol of radiolabeled DNA oligonucleotide
(20,000 cpm/pmol), 10 mM Tris-HCl (pH 8.0), 10 mM
MgCl2, 50 mM KCl, 1 mM DTT, 0.02 mg/ml poly(dI-dC),
0.2 mg/ml bovine serum albumin, 0.04% NP-40, 10%
glycerol, and the indicated concentrations of purified
Zap1DBD. After incubation for 1 hour at room tempera-
ture, the samples were resolved on 6% polyacrylamide
gels. Gels were dried onto blotting paper, and the signals
were visualized by autoradiography.BMC Genomics 2008, 9:370 http://www.biomedcentral.com/1471-2164/9/370
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Microarray data
All microarray data can be downloaded from the Gene
Expression Omnibus database under accession number
GSE11983.
Abbreviations
ZRE- Zinc-responsive domain, MEME- Multiple Expecta-
tion Maximization for Motif Elicitation, RSAT- Regulatory
Sequence Analysis Tools, LZM- low zinc medium, SD-
synthetic defined medium, DBD- DNA binding domain
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